Octapharma

Blood & Tissue Banks · Biologics & Biosimilars
2 legal entities
21Open roles
$253kMedian advertised pay$28k – $254k+100% vs market
28 daysTime to fillmedian of 21 closed roles
119EmployeesRussian tax service · Dec 2025

Facts

as of Nov 13, 2026

Octapharma is a global biopharmaceutical company developing and manufacturing plasma-derived and recombinant therapies for patients worldwide.

It is hiring: 21 open roles, 0 of them posted in the last 30 days. Its stated pay is 100% above the market estimate for the same roles.

Legal name
ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ОКТАФАРМА-ФАРМИМЭКС"
Founded
1983
Employees
119Russian tax service · Dec 2025
Revenue
$1.6M2025 · Russian tax service (ИНН 7704632680)
Legal entities
2 in 2 countries
Open roles
21 in 6 citiesAlion job postings
Register numbers
INN 7704632680 · OGRN 1077746120869
Official records
Wikidata Q2013806
Website
octapharma.com

As of Nov 13, 2026, Alion lists 21 open roles at Octapharma. It was founded in 1983. The median pay stated in its open roles is $253k, across 8 postings that state pay.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ОКТАФАРМА-ФАРМИМЭКС"
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Hiring slowly: few roles were posted lately.

Industrial Engineering is the largest family, 26 of open roles.

0%Remote roles0 of 21
6Hiring offices
Open roles over time−100%
Sep 21This week
Open roles a week: 29 then, 0 now
Where the openings areshare of open roles · trend
Industrial Engineering26▼
Field & Service22▼
Early Careers11
Operations7▲
Finance4▼
HR4
Newest roles
Senior IT Product Owner (m/f/d) - RIM & eDMs
$250k per year · In office · 7+ years exp · Bachelor's Degree · Lachen
Cleaning Operator
In office · 2+ years exp · Springe
What postings ask forlanguages named in open roles
German1257%
English943%
French314%
Swedish15%
Degree asked
Master's Degree 44%Doctoral Degree (PhD) 22%High School Diploma 22%Bachelor's Degree 11%
Experience asked: 6.5 years on average, in 11 postings. 9 postings state a degree.
Contract type
Contract 2Internship 2Full-Time 1
Visa sponsorship: none statedRelocation offered
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family

Pays 100% above the market estimate for the same roles.

$253kMedianmarket estimate $126k
$28k – $254kTypical rangeUSD a year
$333kHighest paying roleGroup Principal Engineer (m/f/d) - Technical Unit
Source: the pay stated in the company's postings, normalised to USD a year

Footprint

Hiring in 6 cities in 5 countries.

6Cities
5Countries
SpringeBusiest site
Loading the map
SiteTypeOpen rolesHires most forEngineering
Springe GermanyPlant / site9Industrial Engineering, Field & Service, DevOps11%
Vienna AustriaRegional office4Early Careers, Management, Science & Research25%
Lachen SwitzerlandRegional office4Product, Analytics, Enterprise Apps50%
Lingolsheim FrancePlant / site3Operations, Field & Service, Industrial Engineering0%
Stockholm SwedenNot classified2Industrial Engineering0%
Dessau-Roßlau GermanyNot classified1Field & Service0%
Source: office addresses in postings and company registers

Financials

Revenue and money on record.

$1.6MRevenue2025
Sources: funding announcements, grant and company registers

Technologies named in job postings at Octapharma over the last 12 months, by layer, with the share of postings for each.

11Technologies in use
22Postings analysed
68/100Stack modernity
Sign in to see how your skills match this stackSign In
Full Octapharma tech stack11 technologies · by team · pay by technology · changes · similar stacks
Source: the technologies named in the company's postings and on its site

Newsroom

#303,664Web rankTranco top 1M
News · sciencedirect.com
A prespecified secondary analysis of the landmark FIBRES trial demonstrated that fibryga (fibrinogen human) significantly reduced 24-hour allogeneic blood-product (ABP) transfusi…
Sources: the outlets named on each headline, each story once